Inhibited Expression of NLRP12 Promotes the Development of Triple-Negative Breast Cancer by Activating the NF-κB Pathway
Cell Biochemistry and Biophysics · 2023-12 · 81 (4) · 727-735
DOI: 10.1007/s12013-023-01166-9 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell Biochemistry and Biophysics, online erschienen am 02.09.2023. Verfasst von Wenbin Kuang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Laboratory, Shenzhen Longhua District Central Hospital, Guangdong Medical University, Shenzhen, 518110, China. Hauptthemen laut MEDLINE: NF-kappa B, Triple Negative Breast Neoplasms. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Guangdong basic and Applied Basic Research Foundation, Shenzhen Longhua District Science and Technology Bureau Project, Shenzhen Longhua District Science and Technology Innovation Special Fund Project.
Abstract (Originalsprache)
NLRP12 can affect the progression of different diseases, including hepatocellular carcinoma. However, no report on triple-negative breast cancer (TNBC) has been found. Thus, this study aimed to explore the role of NLRP12 in TNBC. In our study, immunohistochemistry, real-time quantitative PCR (qPCR), and Western blot assays were used to evaluate NLRP12 expression in TNBC tissues and cells. Then, NLRP12 lentivirus was constructed and infected into MDA-MB-231 and MDA-MB-157 cells with or without PTD-p65-P1 treatment. Next, cells were collected for cell function detection using the following procedures: colony formation assay for proliferation, Transwell for migration and invasion, and Western blot for NF-κB and MAPK pathway-associated proteins. Finally, a xenograft mouse model was applied; the tumor volume and weight were determined, and NLRP12, p-IκBb-α, and p-IκBb-α expressions were evaluated using qPCR and Western blot. Results indicated that NLRP12 was lowly expressed in TNBC tissues and cells. The inhibition of NLRP12 could induce the proliferation, migration, and invasion of TNBC cells, which also could be reversed by inhibiting the NF-κB pathway (PTD-p65-P1). Moreover, silencing of NLRP12 could upregulate p-IκBb-α, while IκBb-α, p-ERK, ERK, p-p38, p38, p-JNK, and JNK expressions remained unchanged, thereby indicating that only the NF-κB pathway could be activated by NLRP12 silencing. Furthermore, the xenograft mouse model confirmed the abovementioned findings. Therefore, the low expression of NLRP12 promoted the proliferation, migration, and invasion in TNBC cells by activating the NF-κB pathway. This study might provide insights into TNBC therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Laboratory, Shenzhen Longhua District Central Hospital, Guangdong Medical University, Shenzhen, 518110, China.
- Laboratory Medicine, Guangdong Medical University, Zhanjiang, 524023, China.
- Department of Pathology, Shenzhen Longhua District Central Hospital, Guangdong Medical University, Shenzhen, 518110, China.
- Department of Clinical Laboratory, Shenzhen Longhua District Central Hospital, Guangdong Medical University, Shenzhen, 518110, China. grace819@126.com.
Förderung
- Guangdong basic and Applied Basic Research Foundation
- Shenzhen Longhua District Science and Technology Bureau Project
- Shenzhen Longhua District Science and Technology Innovation Special Fund Project
Zitieren
APA
Kuang, W., Gu, Q., Zhou, Y., Xiao, X., He, D., & Deng, Q. (2023). Inhibited Expression of NLRP12 Promotes the Development of Triple-Negative Breast Cancer by Activating the NF-κB Pathway. Cell Biochemistry and Biophysics, 81(4), 727-735. https://doi.org/10.1007/s12013-023-01166-9
Vancouver
Kuang W, Gu Q, Zhou Y, Xiao X, He D, Deng Q. Inhibited Expression of NLRP12 Promotes the Development of Triple-Negative Breast Cancer by Activating the NF-κB Pathway. Cell Biochemistry and Biophysics. 2023;81(4):727-735. doi:10.1007/s12013-023-01166-9
BibTeX
@article{Kuang2023,
author = {Kuang, Wenbin and Gu, Qingdan and Zhou, Ying and Xiao, Xiaoqin and He, Dabao and Deng, Qiuchan},
title = {Inhibited Expression of NLRP12 Promotes the Development of Triple-Negative Breast Cancer by Activating the NF-κB Pathway},
journal = {Cell Biochemistry and Biophysics},
year = {2023},
volume = {81},
number = {4},
pages = {727--735},
doi = {10.1007/s12013-023-01166-9}
}
EUVIMED